Índice Bovespa

US Dollar vs BRL

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

ADIL Adial Pharmaceuticals Inc

1,25

-0,03 (-2,34%)

Última atualização: 14:33:37

Atrasado em 15 minutos

Form EFFECT - Notice of Effectiveness

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024

Click aqui para mais gráficos Adial Pharmaceuticals.

Adial Pharmaceuticals (NASDAQ:ADIL)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024

Click aqui para mais gráficos Adial Pharmaceuticals.

Notícias Adial Pharmaceuticals Inc

Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Quarta, 5 de Junho de 2024 (2 semanas atrás) • GlobeNewswire Inc.

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th
Quarta, 29 de Maio de 2024 (3 semanas atrás) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Quarta, 15 de Maio de 2024 (1 mês atrás) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Terça, 14 de Maio de 2024 (1 mês atrás) • Edgar (US Regulatory)

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office
Segunda, 22 de Abril de 2024 (2 meses atrás) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Quarta, 10 de Abril de 2024 (2 meses atrás) • GlobeNewswire Inc.

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
Terça, 2 de Abril de 2024 (3 meses atrás) • GlobeNewswire Inc.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds
Sexta, 1 de Março de 2024 (4 meses atrás) • GlobeNewswire Inc.

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
Quarta, 28 de Fevereiro de 2024 (4 meses atrás) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Quarta, 14 de Fevereiro de 2024 (4 meses atrás) • Edgar (US Regulatory)

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office
Terça, 13 de Fevereiro de 2024 (4 meses atrás) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Quinta, 25 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Adial Pharmaceuticals Inc

Índice Bovespa

MAGAZINE LUIZA ON

TRIUNFO PART ON

LOJAS MARISA ON

SID NACIONAL ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições